Organon & Co. (OGN) Financials

$9.12 +0.43 (+4.95%)

Closing price 03:59 PM Eastern

Extended Trading

$9.10 -0.02 (-0.21%)

As of 08:00 PM Eastern

Annual Income Statements for Organon & Co.

This table shows Organon & Co.'s income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Net Income / (Loss) Attributable to Common Shareholders	864	1,023	917	1,351	2,160	3,218
Consolidated Net Income / (Loss)	864	1,023	917	1,351	2,160	3,218
Net Income / (Loss) Continuing Operations	864	1,023	917	1,351	2,256	3,306
Total Pre-Tax Income	807	673	1,122	1,529	2,752	3,696
Total Operating Income	1,374	1,257	1,570	1,791	2,787	3,762
Total Gross Profit	3,715	3,748	3,880	3,905	4,413	5,503
Total Revenue	6,403	6,263	6,174	6,304	6,532	7,777
Operating Revenue	6,403	6,263	6,174	6,304	6,532	7,777
Total Cost of Revenue	2,688	2,515	2,294	2,399	2,119	2,274
Operating Cost of Revenue	2,688	2,515	2,294	2,399	2,119	2,274
Total Operating Expenses	2,341	2,491	2,310	2,114	1,626	1,741
Selling, General & Admin Expense	1,760	1,893	1,704	1,668	1,356	1,443
Research & Development Expense	550	536	578	443	210	220
Restructuring Charge	31	62	28	3.00	60	78
Total Other Income / (Expense), net	-567	-584	-448	-262	-35	-66
Interest Expense	541	542	437	258	0.00	-
Other Income / (Expense), net	-26	-42	-11	-4.00	-35	-66
Income Tax Expense	-57	-350	205	178	496	390
Basic Earnings per Share	$3.36	$4.01	$3.61	$5.33	$8.52	$12.69
Weighted Average Basic Shares Outstanding	257.05M	255.24M	254.08M	253.54M	253.52M	253.52M
Diluted Earnings per Share	$3.33	$3.99	$3.59	$5.31	$8.52	$12.69
Weighted Average Diluted Shares Outstanding	259.15M	256.27M	255.17M	254.19M	253.52M	253.52M
Weighted Average Basic & Diluted Shares Outstanding	257.95M	255.64M	254.38M	253.64M	-	-
Cash Dividends to Common per Share	$1.12	$1.12	$1.12	$0.56	-	-

This table shows Organon & Co.'s income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	87	109	359	195	201	546	58	242	177	108	227
Consolidated Net Income / (Loss)	87	109	359	195	201	546	58	242	177	108	227
Net Income / (Loss) Continuing Operations	87	109	359	195	201	546	58	242	177	108	227
Total Pre-Tax Income	101	129	207	235	236	104	80	254	235	111	282
Total Operating Income	233	288	339	371	376	254	232	389	382	266	398
Total Gross Profit	841	896	923	939	957	915	907	968	958	895	986
Total Revenue	1,513	1,592	1,582	1,607	1,622	1,598	1,519	1,608	1,538	1,485	1,537
Operating Revenue	1,513	-	1,582	1,607	-	-	1,519	1,608	-	1,485	1,537
Total Cost of Revenue	672	696	659	668	665	683	612	640	580	590	551
Operating Cost of Revenue	672	696	659	668	665	683	612	640	580	590	551
Total Operating Expenses	608	608	584	568	581	661	675	579	576	629	588
Selling, General & Admin Expense	420	470	422	437	431	469	538	451	435	470	440
Research & Development Expense	102	130	162	131	127	134	137	128	137	142	137
Restructuring Charge	86	8.00	0.00	0.00	23	58	0.00	0.00	4.00	17	11
Total Other Income / (Expense), net	-132	-159	-132	-136	-140	-150	-152	-135	-147	-155	-116
Interest Expense	136	153	126	131	131	143	134	133	132	134	108
Other Income / (Expense), net	4.00	-6.00	-6.00	-5.00	-9.00	-7.00	-18	-2.00	-15	-21	-8.00
Income Tax Expense	14	20	-152	40	35	-442	22	12	58	3.00	55
Basic Earnings per Share	$0.34	$0.43	$1.39	$0.76	$0.78	$2.13	$0.23	$0.95	$0.70	$0.43	$0.89
Weighted Average Basic Shares Outstanding	257.86M	257.05M	257.50M	257.29M	255.70M	255.24M	255.59M	255.34M	254.39M	254.08M	254.35M
Diluted Earnings per Share	$0.33	$0.42	$1.38	$0.75	$0.78	$2.12	$0.23	$0.95	$0.69	$0.42	$0.89
Weighted Average Diluted Shares Outstanding	261.00M	259.15M	259.76M	258.60M	258.36M	256.27M	256.35M	255.95M	256.17M	255.17M	255.07M
Weighted Average Basic & Diluted Shares Outstanding	259.96M	257.95M	257.54M	257.47M	257.17M	255.64M	255.61M	255.57M	255.06M	254.38M	254.36M
Cash Dividends to Common per Share	$0.28	-	$0.28	$0.28	$0.28	-	$0.28	$0.28	$0.28	-	$0.28

This table details how cash moves in and out of Organon & Co.'s business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Net Change in Cash & Equivalents	-18	-13	-31	667	-246	75
Net Cash From Operating Activities	939	799	858	2,160	2,284	3,020
Net Cash From Continuing Operating Activities	939	799	858	2,160	2,284	3,020
Net Income / (Loss) Continuing Operations	864	1,023	917	1,351	2,256	3,306
Consolidated Net Income / (Loss)	864	1,023	917	1,351	-	-
Depreciation Expense	132	120	96	92	56	49
Amortization Expense	145	116	116	103	86	284
Non-Cash Adjustments To Reconcile Net Income	225	180	199	200	35	41
Changes in Operating Assets and Liabilities, net	-427	-640	-470	414	-149	-660
Net Cash From Investing Activities	-513	-260	-420	-481	-250	-88
Net Cash From Continuing Investing Activities	-513	-260	-420	-481	-250	-88
Purchase of Property, Plant & Equipment	-175	-251	-196	-192	-255	-92
Acquisitions	-342	-10	-231	-296	0.00	0.00
Sale of Property, Plant & Equipment	4.00	1.00	7.00	7.00	5.00	4.00
Net Cash From Financing Activities	-368	-569	-433	-977	-2,022	-2,932
Net Cash From Continuing Financing Activities	-368	-569	-433	-977	-2,022	-2,932
Repayment of Debt	-1,235	-338	-108	-1,742	0.00	0.00
Payment of Dividends	-297	-294	-290	-145	0.00	0.00
Issuance of Debt	1,186	80	0.00	9,470	1,512	0.00
Other Financing Activities, net	-22	-17	-35	-8,560	-3,534	-2,932
Effect of Exchange Rate Changes	-76	17	-36	23	-	31

This table details how cash moves in and out of Organon & Co.'s business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-128	-88	59	129	-118	279	88	-133	-247	207	-46
Net Cash From Operating Activities	75	390	141	332	76	397	261	27	114	267	317
Net Cash From Continuing Operating Activities	75	390	141	332	76	397	261	27	114	267	317
Net Income / (Loss) Continuing Operations	87	109	359	195	201	546	58	242	177	108	227
Consolidated Net Income / (Loss)	87	109	359	195	201	546	58	242	177	108	227
Depreciation Expense	34	34	34	32	32	32	32	28	28	24	25
Amortization Expense	50	43	35	34	33	28	29	30	29	28	32
Non-Cash Adjustments To Reconcile Net Income	35	71	76	50	28	55	44	41	40	52	17
Changes in Operating Assets and Liabilities, net	-131	133	-363	21	-218	-264	98	-314	-160	55	16
Net Cash From Investing Activities	-172	-296	-75	-46	-96	-81	-55	-70	-54	-61	-213
Net Cash From Continuing Investing Activities	-172	-296	-75	-46	-96	-81	-55	-70	-54	-61	-213
Purchase of Property, Plant & Equipment	-32	-55	-42	-32	-46	-79	-55	-71	-46	-63	-55
Acquisitions	-140	-243	-34	-15	-50	-2.00	-	-	-8.00	-2.00	-160
Net Cash From Financing Activities	-75	-82	-78	-134	-74	-77	-78	-88	-326	-82	-77
Net Cash From Continuing Financing Activities	-75	-82	-78	-134	-74	-77	-78	-88	-326	-82	-77
Repayment of Debt	-93	-154	-2.00	-1,077	-2.00	-2.00	-2.00	-82	-252	-2.00	-
Payment of Dividends	-71	-74	-74	-79	-70	-73	-74	-74	-73	-73	-74
Issuance of Debt	90	150	-	-	-	-	-	-	-	-	-
Other Financing Activities, net	-1.00	-4.00	-2.00	-14	-2.00	-2.00	-2.00	-12	-1.00	-7.00	-3.00
Effect of Exchange Rate Changes	44	-100	71	-23	-24	40	-40	-2.00	19	83	-73

This table presents Organon & Co.'s assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Total Assets	13,101	12,058	10,955	10,681	10,109
Total Current Assets	4,348	4,508	3,931	3,760	3,567
Cash & Equivalents	675	693	706	737	12
Accounts Receivable	1,358	1,744	1,475	1,382	1,038
Inventories, net	1,321	1,315	1,003	915	913
Other Current Assets	994	756	747	726	930
Plant, Property, & Equipment, net	1,168	1,183	1,018	973	984
Total Noncurrent Assets	7,585	6,367	6,006	5,948	5,558
Goodwill	4,680	4,603	4,603	4,603	4,603
Intangible Assets	1,414	533	649	651	503
Other Noncurrent Operating Assets	1,491	1,231	754	-	361
Total Liabilities & Shareholders' Equity	13,101	12,058	10,955	10,681	10,109
Total Liabilities	12,629	12,128	11,847	12,189	4,623
Total Current Liabilities	2,718	2,918	2,512	2,597	2,673
Short-Term Debt	20	9.00	8.00	9.00	0.00
Accounts Payable	1,153	1,314	1,132	1,382	1,598
Accrued Expenses	1,411	1,389	1,188	1,021	659
Current Deferred & Payable Income Tax Liabilities	134	206	184	185	288
Total Noncurrent Liabilities	9,911	9,210	9,335	9,592	1,950
Long-Term Debt	8,860	8,751	8,905	9,125	0.00
Noncurrent Deferred & Payable Income Tax Liabilities	74	47	19	4.00	128
Other Noncurrent Operating Liabilities	977	412	411	463	1,739
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	472	-70	-892	-1,508	5,486
Total Preferred & Common Equity	472	-70	-892	-1,508	5,486
Total Common Equity	472	-70	-892	-1,508	5,486
Common Stock	111	28	3.00	3.00	0.00
Retained Earnings	1,010	443	-331	-998	0.00
Accumulated Other Comprehensive Income / (Loss)	-649	-541	-564	-513	-622

This table presents Organon & Co.'s assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	13,156	12,752	12,154	11,891	11,012	10,979	10,763	10,437
Total Current Assets	4,371	4,756	4,509	4,196	4,050	3,958	3,780	3,592
Cash & Equivalents	547	763	704	575	414	326	459	499
Accounts Receivable	1,457	1,685	1,617	1,547	1,648	1,672	1,445	1,440
Inventories, net	1,362	1,383	1,287	1,263	1,186	1,199	1,121	879
Other Current Assets	1,005	925	901	811	802	761	755	774
Plant, Property, & Equipment, net	1,197	1,204	1,162	1,180	1,096	1,110	1,055	906
Total Noncurrent Assets	7,588	6,792	6,483	6,515	5,866	5,911	5,928	5,939
Goodwill	4,680	4,603	4,603	4,603	4,603	4,603	4,603	4,603
Intangible Assets	1,417	763	684	718	561	592	621	670
Noncurrent Deferred & Refundable Income Taxes	1,491	1,426	1,196	1,194	702	716	704	-
Total Liabilities & Shareholders' Equity	13,156	12,752	12,154	11,891	11,012	10,979	10,763	10,437
Total Liabilities	12,614	12,259	12,010	11,843	11,601	11,534	11,500	11,503
Total Current Liabilities	2,615	2,790	2,755	2,545	2,491	2,387	2,346	2,328
Short-Term Debt	20	10	9.00	9.00	8.00	8.00	8.00	8.00
Accounts Payable	1,006	1,092	1,243	955	1,067	1,115	996	1,028
Accrued Expenses	1,413	1,458	1,302	1,385	1,255	1,101	1,150	1,075
Current Deferred & Payable Income Tax Liabilities	176	230	201	196	161	163	192	217
Total Noncurrent Liabilities	9,999	9,469	9,255	9,298	9,110	9,147	9,154	9,175
Long-Term Debt	8,936	8,739	8,647	8,705	8,646	8,722	8,703	8,691
Noncurrent Deferred & Payable Income Tax Liabilities	69	56	60	44	43	32	30	43
Other Noncurrent Operating Liabilities	994	674	548	549	421	393	421	441
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	542	493	144	48	-589	-555	-737	-1,066
Total Preferred & Common Equity	542	493	144	48	-589	-555	-737	-1,066
Total Common Equity	542	493	144	48	-589	-555	-737	-1,066
Common Stock	133	89	66	52	3.00	3.00	3.00	3.00
Retained Earnings	1,026	975	690	573	-16	-25	-206	-383
Accumulated Other Comprehensive Income / (Loss)	-617	-571	-612	-577	-576	-533	-534	-686

This table displays calculated financial ratios and metrics derived from Organon & Co.'s official financial filings.

Metric	2024	2023	2022	2021	2020	2019
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Growth Metrics	-	-	-	-	-	-
Revenue Growth	2.24%	1.44%	-2.06%	-3.49%	-16.01%	0.00%
EBITDA Growth	11.99%	-18.07%	-10.65%	-31.51%	-28.17%	0.00%
EBIT Growth	10.95%	-22.07%	-12.76%	-35.07%	-25.54%	0.00%
NOPAT Growth	-23.01%	48.91%	-18.92%	-30.73%	-32.11%	0.00%
Net Income Growth	-15.54%	11.56%	-32.12%	-37.45%	-32.88%	0.00%
EPS Growth	-16.54%	11.14%	-32.39%	-37.68%	-32.86%	0.00%
Operating Cash Flow Growth	17.52%	-6.88%	-60.28%	-5.43%	-24.37%	0.00%
Free Cash Flow Firm Growth	-35.62%	43.35%	321.77%	85.33%	0.00%	0.00%
Invested Capital Growth	8.50%	9.32%	6.18%	40.02%	0.00%	0.00%
Revenue Q/Q Growth	-0.09%	1.84%	-1.88%	-0.16%	0.00%	0.00%
EBITDA Q/Q Growth	4.30%	1.75%	-5.24%	-7.69%	0.00%	0.00%
EBIT Q/Q Growth	3.85%	1.42%	-5.34%	-9.70%	0.00%	0.00%
NOPAT Q/Q Growth	-33.27%	77.11%	-2.30%	-5.25%	0.00%	0.00%
Net Income Q/Q Growth	-33.59%	74.87%	-9.30%	-10.94%	0.00%	0.00%
EPS Q/Q Growth	-33.80%	74.24%	-9.11%	-11.06%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	-0.74%	19.43%	34.48%	-16.83%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	-42.53%	118.71%	0.67%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	2.34%	4.52%	2.54%	3.25%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	58.02%	59.84%	62.84%	61.94%	67.56%	70.76%
EBITDA Margin	25.38%	23.17%	28.68%	31.44%	44.31%	51.81%
Operating Margin	21.46%	20.07%	25.43%	28.41%	42.67%	48.37%
EBIT Margin	21.05%	19.40%	25.25%	28.35%	42.13%	47.52%
Profit (Net Income) Margin	13.49%	16.33%	14.85%	21.43%	33.07%	41.38%
Tax Burden Percent	107.06%	152.01%	81.73%	88.36%	78.49%	87.07%
Interest Burden Percent	59.87%	55.39%	71.97%	85.56%	100.00%	100.00%
Effective Tax Rate	-7.06%	-52.01%	18.27%	11.64%	18.02%	10.55%
Return on Invested Capital (ROIC)	17.64%	24.96%	18.07%	26.80%	92.87%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	10.18%	14.05%	13.66%	20.89%	136.93%	0.00%
Return on Net Nonoperating Assets (RNNOA)	412.21%	-237.64%	-94.48%	41.12%	-14.13%	0.00%
Return on Equity (ROE)	429.85%	-212.68%	-76.42%	67.92%	78.75%	0.00%
Cash Return on Invested Capital (CROIC)	9.49%	16.05%	12.07%	-6.55%	-107.13%	0.00%
Operating Return on Assets (OROA)	10.72%	10.56%	14.41%	17.19%	27.22%	0.00%
Return on Assets (ROA)	6.87%	8.89%	8.48%	13.00%	21.37%	0.00%
Return on Common Equity (ROCE)	429.85%	-212.68%	-76.42%	67.92%	78.75%	0.00%
Return on Equity Simple (ROE_SIMPLE)	183.05%	-1,461.43%	-102.80%	-89.59%	39.37%	0.00%
Net Operating Profit after Tax (NOPAT)	1,471	1,911	1,283	1,582	2,285	3,365
NOPAT Margin	22.97%	30.51%	20.78%	25.10%	34.98%	43.27%
Net Nonoperating Expense Percent (NNEP)	7.46%	10.91%	4.41%	5.91%	-44.06%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	15.73%	21.99%	16.00%	-	-	-
Cost of Revenue to Revenue	41.98%	40.16%	37.16%	38.06%	32.44%	29.24%
SG&A Expenses to Revenue	27.49%	30.23%	27.60%	26.46%	20.76%	18.55%
R&D to Revenue	8.59%	8.56%	9.36%	7.03%	3.21%	2.83%
Operating Expenses to Revenue	36.56%	39.77%	37.42%	33.53%	24.89%	22.39%
Earnings before Interest and Taxes (EBIT)	1,348	1,215	1,559	1,787	2,752	3,696
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,625	1,451	1,771	1,982	2,894	4,029
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	7.99	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.59	0.54	1.00	1.05	0.00	0.00
Price to Earnings (P/E)	4.37	3.33	6.74	4.91	0.00	0.00
Dividend Yield	7.64%	8.40%	6.92%	2.14%	0.00%	0.00%
Earnings Yield	22.90%	30.03%	14.84%	20.37%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.38	1.43	1.97	2.18	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	1.87	1.83	2.33	2.38	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	7.37	7.91	8.12	7.58	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	8.89	9.44	9.23	8.41	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	8.14	6.01	11.21	9.50	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	12.76	14.36	16.77	6.96	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	15.14	9.34	16.78	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	18.81	-125.14	-9.99	-6.06	0.00	0.00
Long-Term Debt to Equity	18.77	-125.01	-9.98	-6.05	0.00	0.00
Financial Leverage	40.48	-16.92	-6.92	1.97	-0.10	0.00
Leverage Ratio	62.58	-23.92	-9.02	5.23	1.84	0.00
Compound Leverage Factor	37.47	-13.25	-6.49	4.47	1.84	0.00
Debt to Total Capital	94.95%	100.81%	111.12%	119.77%	0.00%	0.00%
Short-Term Debt to Total Capital	0.21%	0.10%	0.10%	0.12%	0.00%	0.00%
Long-Term Debt to Total Capital	94.74%	100.70%	111.02%	119.66%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	5.05%	-0.81%	-11.12%	-19.77%	100.00%	0.00%
Debt to EBITDA	5.46	6.04	5.03	4.61	0.00	0.00
Net Debt to EBITDA	5.05	5.56	4.63	4.24	0.00	0.00
Long-Term Debt to EBITDA	5.45	6.03	5.03	4.60	0.00	0.00
Debt to NOPAT	6.04	4.58	6.95	5.77	0.00	0.00
Net Debt to NOPAT	5.58	4.22	6.40	5.31	0.00	0.00
Long-Term Debt to NOPAT	6.02	4.58	6.94	5.77	0.00	0.00
Altman Z-Score	1.26	1.23	1.46	1.47	0.00	0.00
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	1.60	1.54	1.56	1.45	1.33	0.00
Quick Ratio	0.75	0.84	0.87	0.82	0.39	0.00
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	791	1,229	857	-387	-2,635	0.00
Operating Cash Flow to CapEx	549.12%	319.60%	453.97%	1,167.57%	913.60%	3,431.82%
Free Cash Flow to Firm to Interest Expense	1.46	2.27	1.96	-1.50	0.00	0.00
Operating Cash Flow to Interest Expense	1.74	1.47	1.96	8.37	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	1.42	1.01	1.53	7.66	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	0.51	0.54	0.57	0.61	0.65	0.00
Accounts Receivable Turnover	4.13	3.89	4.32	5.21	6.29	0.00
Inventory Turnover	2.04	2.17	2.39	2.62	2.32	0.00
Fixed Asset Turnover	5.45	5.69	6.20	6.44	6.64	0.00
Accounts Payable Turnover	2.18	2.06	1.83	1.61	1.33	0.00
Days Sales Outstanding (DSO)	88.41	93.80	84.45	70.06	58.00	0.00
Days Inventory Outstanding (DIO)	178.97	168.20	152.59	139.06	157.27	0.00
Days Payable Outstanding (DPO)	167.50	177.49	200.00	226.70	275.26	0.00
Cash Conversion Cycle (CCC)	99.89	84.51	37.04	-17.58	-59.99	0.00
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	8,677	7,997	7,315	6,889	4,920	0.00
Invested Capital Turnover	0.77	0.82	0.87	1.07	2.66	0.00
Increase / (Decrease) in Invested Capital	680	682	426	1,969	4,920	0.00
Enterprise Value (EV)	11,978	11,474	14,385	15,029	0.00	0.00
Market Capitalization	3,773	3,407	6,178	6,632	0.00	0.00
Book Value per Share	$1.83	($0.27)	($3.51)	($5.95)	$21.64	$0.00
Tangible Book Value per Share	($21.83)	($20.37)	($24.15)	($26.67)	$1.50	$0.00
Total Capital	9,352	8,690	8,021	7,626	5,486	0.00
Total Debt	8,880	8,760	8,913	9,134	0.00	0.00
Total Long-Term Debt	8,860	8,751	8,905	9,125	0.00	0.00
Net Debt	8,205	8,067	8,207	8,397	-12	0.00
Capital Expenditures (CapEx)	171	250	189	185	250	88
Debt-free, Cash-free Net Working Capital (DFCFNWC)	975	906	721	435	882	0.00
Debt-free Net Working Capital (DFNWC)	1,650	1,599	1,427	1,172	894	0.00
Net Working Capital (NWC)	1,630	1,590	1,419	1,163	894	0.00
Net Nonoperating Expense (NNE)	607	888	366	231	125	147
Net Nonoperating Obligations (NNO)	8,205	8,067	8,207	8,397	-566	0.00
Total Depreciation and Amortization (D&A)	277	236	212	195	142	333
Debt-free, Cash-free Net Working Capital to Revenue	15.23%	14.47%	11.68%	6.90%	13.50%	0.00%
Debt-free Net Working Capital to Revenue	25.77%	25.53%	23.11%	18.59%	13.69%	0.00%
Net Working Capital to Revenue	25.46%	25.39%	22.98%	18.45%	13.69%	0.00%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.36	$4.01	$3.61	$5.33	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	257.05M	255.24M	254.08M	253.54M	0.00	0.00
Adjusted Diluted Earnings per Share	$3.33	$3.99	$3.59	$5.31	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	259.15M	256.27M	255.17M	254.19M	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	257.95M	255.64M	254.38M	253.64M	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	984	923	1,306	1,585	2,334	3,435
Normalized NOPAT Margin	15.36%	14.74%	21.15%	25.15%	35.73%	44.17%
Pre Tax Income Margin	12.60%	10.75%	18.17%	24.25%	42.13%	47.52%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	2.49	2.24	3.57	6.93	0.00	0.00
NOPAT to Interest Expense	2.72	3.53	2.94	6.13	0.00	0.00
EBIT Less CapEx to Interest Expense	2.18	1.78	3.14	6.21	0.00	0.00
NOPAT Less CapEx to Interest Expense	2.40	3.06	2.50	5.42	0.00	0.00
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	34.38%	28.74%	31.62%	10.73%	0.00%	0.00%
Augmented Payout Ratio	34.38%	28.74%	31.62%	10.73%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Organon & Co.'s official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-6.72%	-0.38%	4.15%	-0.06%	5.46%	7.61%	-1.17%	1.45%	-1.85%	-7.36%	-3.94%
EBITDA Growth	-25.69%	16.94%	46.18%	-2.92%	1.89%	3.37%	-38.48%	2.30%	-28.38%	-24.81%	-17.22%
EBIT Growth	-35.42%	14.17%	55.61%	-5.43%	0.00%	0.82%	-45.13%	0.52%	-31.91%	-26.43%	-20.08%
NOPAT Growth	-37.33%	-81.75%	249.54%	-16.94%	11.30%	415.24%	-47.50%	22.52%	-31.69%	-4.31%	-21.42%
Net Income Growth	-56.72%	-80.04%	518.97%	-19.42%	13.56%	405.56%	-74.45%	3.42%	-49.14%	-46.53%	-29.72%
EPS Growth	-57.69%	-80.19%	500.00%	-21.05%	13.04%	404.76%	-74.16%	3.26%	-49.26%	-46.15%	-29.92%
Operating Cash Flow Growth	-1.32%	-1.76%	-45.98%	1,129.63%	-33.33%	48.69%	-17.67%	-82.12%	-7.32%	468.09%	-13.86%
Free Cash Flow Firm Growth	-60.14%	-167.02%	31.17%	122.76%	-355.17%	489.68%	-146.29%	-19.09%	96.50%	90.16%	97.74%
Invested Capital Growth	9.33%	8.50%	10.82%	3.15%	8.94%	9.32%	7.25%	8.85%	5.10%	6.18%	6.92%
Revenue Q/Q Growth	-4.96%	0.63%	-1.56%	-0.92%	1.50%	5.20%	-5.53%	4.55%	3.57%	-3.38%	-3.03%
EBITDA Q/Q Growth	-10.59%	-10.70%	-6.94%	0.00%	47.95%	11.64%	-38.20%	4.95%	50.35%	-33.56%	2.76%
EBIT Q/Q Growth	-15.96%	-15.32%	-9.02%	-0.27%	58.19%	15.42%	-44.70%	5.45%	59.57%	-37.18%	1.30%
NOPAT Q/Q Growth	-17.52%	-58.61%	90.98%	-3.87%	-74.48%	692.81%	-54.62%	28.81%	17.81%	-19.22%	5.91%
Net Income Q/Q Growth	-20.18%	-69.64%	84.10%	-2.99%	-63.19%	841.38%	-76.03%	36.72%	63.89%	-52.42%	-2.99%
EPS Q/Q Growth	-21.43%	-69.57%	84.00%	-3.85%	-63.21%	821.74%	-75.79%	37.68%	64.29%	-52.81%	-3.26%
Operating Cash Flow Q/Q Growth	-80.77%	176.60%	-57.53%	336.84%	-80.86%	52.11%	866.67%	-76.32%	-57.30%	-15.77%	109.93%
Free Cash Flow Firm Q/Q Growth	-29.00%	-81.88%	-494.52%	117.30%	-161.42%	286.78%	-30.45%	-245.98%	57.49%	-18.05%	36.92%
Invested Capital Q/Q Growth	3.16%	2.34%	4.73%	-1.11%	2.38%	4.52%	-2.52%	4.44%	2.73%	2.54%	-1.07%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	55.58%	56.28%	58.34%	58.43%	59.00%	57.26%	59.71%	60.20%	62.29%	60.27%	64.15%
EBITDA Margin	21.22%	22.55%	25.41%	26.88%	26.63%	19.21%	18.10%	27.67%	27.57%	20.00%	29.08%
Operating Margin	15.40%	18.09%	21.43%	23.09%	23.18%	15.89%	15.27%	24.19%	24.84%	17.91%	25.89%
EBIT Margin	15.66%	17.71%	21.05%	22.78%	22.63%	15.46%	14.09%	24.07%	23.86%	16.50%	25.37%
Profit (Net Income) Margin	5.75%	6.85%	22.69%	12.13%	12.39%	34.17%	3.82%	15.05%	11.51%	7.27%	14.77%
Tax Burden Percent	86.14%	84.50%	173.43%	82.98%	85.17%	525.00%	72.50%	95.28%	75.32%	97.30%	80.50%
Interest Burden Percent	42.62%	45.74%	62.16%	64.21%	64.31%	42.11%	37.38%	65.63%	64.03%	45.31%	72.31%
Effective Tax Rate	13.86%	15.50%	-73.43%	17.02%	14.83%	-425.00%	27.50%	4.72%	24.68%	2.70%	19.50%
Return on Invested Capital (ROIC)	9.74%	11.74%	29.53%	15.25%	15.96%	68.26%	9.21%	18.88%	15.68%	15.15%	19.00%
ROIC Less NNEP Spread (ROIC-NNEP)	8.37%	10.09%	26.71%	13.87%	14.51%	58.59%	7.87%	17.34%	14.35%	13.33%	17.87%
Return on Net Nonoperating Assets (RNNOA)	234.73%	408.36%	-4,514.71%	-551.91%	-345.10%	-991.10%	-78.19%	-171.72%	-120.24%	-92.25%	-109.77%
Return on Equity (ROE)	244.48%	420.10%	-4,485.18%	-536.66%	-329.14%	-922.84%	-68.98%	-152.84%	-104.56%	-77.10%	-90.77%
Cash Return on Invested Capital (CROIC)	7.12%	9.49%	17.07%	20.23%	15.90%	16.05%	7.60%	7.65%	10.61%	12.07%	12.33%
Operating Return on Assets (OROA)	7.87%	9.02%	11.35%	12.50%	12.68%	8.41%	8.08%	13.75%	13.73%	9.42%	14.67%
Return on Assets (ROA)	2.89%	3.49%	12.24%	6.66%	6.94%	18.60%	2.19%	8.60%	6.62%	4.15%	8.54%
Return on Common Equity (ROCE)	244.48%	420.10%	-4,485.18%	-536.66%	-329.14%	-922.84%	-68.98%	-152.84%	-104.56%	-77.10%	-90.77%
Return on Equity Simple (ROE_SIMPLE)	138.38%	0.00%	263.89%	694.44%	2,181.25%	0.00%	-99.32%	-135.86%	-101.22%	0.00%	-94.84%
Net Operating Profit after Tax (NOPAT)	201	243	588	308	320	1,334	168	371	288	259	320
NOPAT Margin	13.27%	15.29%	37.16%	19.16%	19.74%	83.45%	11.07%	23.05%	18.71%	17.43%	20.84%
Net Nonoperating Expense Percent (NNEP)	1.37%	1.65%	2.82%	1.38%	1.45%	9.68%	1.34%	1.54%	1.33%	1.82%	1.13%
Return On Investment Capital (ROIC_SIMPLE)	2.11%	2.60%	-	-	-	15.35%	-	-	-	3.23%	-
Cost of Revenue to Revenue	44.42%	43.72%	41.66%	41.57%	41.00%	42.74%	40.29%	39.80%	37.71%	39.73%	35.85%
SG&A Expenses to Revenue	27.76%	29.52%	26.68%	27.19%	26.57%	29.35%	35.42%	28.05%	28.28%	31.65%	28.63%
R&D to Revenue	6.74%	8.17%	10.24%	8.15%	7.83%	8.39%	9.02%	7.96%	8.91%	9.56%	8.91%
Operating Expenses to Revenue	40.19%	38.19%	36.92%	35.35%	35.82%	41.36%	44.44%	36.01%	37.45%	42.36%	38.26%
Earnings before Interest and Taxes (EBIT)	237	282	333	366	367	247	214	387	367	245	390
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	321	359	402	432	432	307	275	445	424	297	447
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	7.09	7.99	9.99	36.46	97.38	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.61	0.59	0.77	0.83	0.74	0.54	0.67	0.79	0.89	1.00	0.83
Price to Earnings (P/E)	5.12	4.37	3.79	5.25	4.46	3.33	7.09	6.50	7.31	6.74	5.18
Dividend Yield	7.52%	7.64%	5.85%	5.49%	6.12%	8.40%	8.63%	7.29%	6.54%	6.92%	6.79%
Earnings Yield	19.53%	22.90%	26.41%	19.05%	22.40%	30.03%	14.11%	15.39%	13.69%	14.84%	19.29%
Enterprise Value to Invested Capital (EV/IC)	1.37	1.38	1.52	1.63	1.57	1.43	1.62	1.69	1.82	1.97	1.88
Enterprise Value to Revenue (EV/Rev)	1.95	1.87	2.01	2.08	2.02	1.83	2.01	2.16	2.23	2.33	2.14
Enterprise Value to EBITDA (EV/EBITDA)	8.09	7.37	8.29	9.23	8.87	7.91	8.69	8.33	8.63	8.12	7.19
Enterprise Value to EBIT (EV/EBIT)	10.06	8.89	9.95	11.20	10.68	9.44	10.34	9.68	9.99	9.23	8.16
Enterprise Value to NOPAT (EV/NOPAT)	8.92	8.14	5.86	7.10	6.67	6.01	11.48	10.96	11.99	11.21	10.23
Enterprise Value to Operating Cash Flow (EV/OCF)	13.06	12.76	13.65	12.38	16.84	14.36	18.51	18.35	16.14	16.77	21.07
Enterprise Value to Free Cash Flow (EV/FCFF)	20.09	15.14	9.38	8.19	10.27	9.34	22.05	23.10	17.61	16.78	15.79
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	16.52	18.81	17.75	60.11	181.54	-125.14	-14.69	-15.73	-11.82	-9.99	-8.16
Long-Term Debt to Equity	16.49	18.77	17.73	60.05	181.35	-125.01	-14.68	-15.72	-11.81	-9.98	-8.15
Financial Leverage	28.05	40.48	-169.02	-39.80	-23.79	-16.92	-9.93	-9.90	-8.38	-6.92	-6.14
Leverage Ratio	42.45	62.58	-247.54	-56.28	-32.88	-23.92	-12.96	-12.76	-10.75	-9.02	-8.11
Compound Leverage Factor	18.09	28.63	-153.88	-36.14	-21.14	-10.07	-4.84	-8.38	-6.88	-4.08	-5.87
Debt to Total Capital	94.29%	94.95%	94.67%	98.36%	99.45%	100.81%	107.30%	106.79%	109.24%	111.12%	113.97%
Short-Term Debt to Total Capital	0.21%	0.21%	0.11%	0.10%	0.10%	0.10%	0.10%	0.10%	0.10%	0.10%	0.10%
Long-Term Debt to Total Capital	94.08%	94.74%	94.56%	98.26%	99.35%	100.70%	107.20%	106.69%	109.14%	111.02%	113.86%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	5.71%	5.05%	5.33%	1.64%	0.55%	-0.81%	-7.30%	-6.79%	-9.24%	-11.12%	-13.97%
Debt to EBITDA	5.92	5.46	5.62	6.05	6.03	6.04	6.07	5.46	5.49	5.03	4.65
Net Debt to EBITDA	5.55	5.05	5.13	5.56	5.64	5.56	5.78	5.26	5.20	4.63	4.39
Long-Term Debt to EBITDA	5.90	5.45	5.61	6.04	6.03	6.03	6.06	5.46	5.48	5.03	4.65
Debt to NOPAT	6.52	6.04	3.97	4.65	4.54	4.58	8.02	7.19	7.62	6.95	6.62
Net Debt to NOPAT	6.12	5.58	3.62	4.28	4.24	4.22	7.64	6.92	7.22	6.40	6.24
Long-Term Debt to NOPAT	6.50	6.02	3.96	4.65	4.53	4.58	8.01	7.19	7.61	6.94	6.62
Altman Z-Score	0.99	1.00	1.12	1.14	1.11	0.97	1.00	1.10	1.10	1.06	1.09
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.67	1.60	1.70	1.64	1.65	1.54	1.63	1.66	1.61	1.56	1.54
Quick Ratio	0.77	0.75	0.88	0.84	0.83	0.84	0.83	0.84	0.81	0.87	0.83
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-563	-437	-240	61	-352	652	-349	-267	-77	-167	-142
Operating Cash Flow to CapEx	234.38%	735.85%	343.90%	1,037.50%	165.22%	502.53%	474.55%	38.03%	247.83%	452.54%	598.11%
Free Cash Flow to Firm to Interest Expense	-4.14	-2.85	-1.91	0.46	-2.69	4.56	-2.60	-2.01	-0.59	-1.25	-1.31
Operating Cash Flow to Interest Expense	0.55	2.55	1.12	2.53	0.58	2.78	1.95	0.20	0.86	1.99	2.94
Operating Cash Flow Less CapEx to Interest Expense	0.32	2.20	0.79	2.29	0.23	2.22	1.54	-0.33	0.52	1.55	2.44
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.50	0.51	0.54	0.55	0.56	0.54	0.57	0.57	0.58	0.57	0.58
Accounts Receivable Turnover	4.19	4.13	3.85	3.86	4.24	3.89	3.98	3.90	4.44	4.32	4.28
Inventory Turnover	2.05	2.04	2.09	2.13	2.19	2.17	2.36	2.21	2.25	2.39	2.58
Fixed Asset Turnover	5.30	5.45	5.57	5.59	5.68	5.69	6.14	5.98	6.07	6.20	6.72
Accounts Payable Turnover	2.75	2.18	2.49	2.24	2.68	2.06	2.33	2.12	2.24	1.83	1.72
Days Sales Outstanding (DSO)	87.10	88.41	94.91	94.59	86.03	93.80	91.64	93.56	82.18	84.45	85.22
Days Inventory Outstanding (DIO)	177.76	178.97	174.29	171.66	166.38	168.20	154.64	165.06	162.32	152.59	141.36
Days Payable Outstanding (DPO)	132.80	167.50	146.47	162.82	136.16	177.49	156.89	172.44	163.10	200.00	212.47
Cash Conversion Cycle (CCC)	132.07	99.89	122.73	103.42	116.25	84.51	89.39	86.18	81.39	37.04	14.10
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	8,951	8,677	8,479	8,096	8,187	7,997	7,651	7,849	7,515	7,315	7,134
Invested Capital Turnover	0.73	0.77	0.79	0.80	0.81	0.82	0.83	0.82	0.84	0.87	0.91
Increase / (Decrease) in Invested Capital	764	680	828	247	672	682	517	638	365	426	462
Enterprise Value (EV)	12,250	11,978	12,911	13,202	12,813	11,474	12,386	13,304	13,702	14,385	13,441
Market Capitalization	3,841	3,773	4,925	5,250	4,674	3,407	4,146	4,900	5,450	6,178	5,241
Book Value per Share	$2.10	$1.83	$1.91	$0.56	$0.19	($0.27)	($2.30)	($2.18)	($2.90)	($3.51)	($4.19)
Tangible Book Value per Share	($21.54)	($21.83)	($18.93)	($20.00)	($20.62)	($20.37)	($22.51)	($22.54)	($23.43)	($24.15)	($24.92)
Total Capital	9,498	9,352	9,242	8,800	8,762	8,690	8,065	8,175	7,974	8,021	7,633
Total Debt	8,956	8,880	8,749	8,656	8,714	8,760	8,654	8,730	8,711	8,913	8,699
Total Long-Term Debt	8,936	8,860	8,739	8,647	8,705	8,751	8,646	8,722	8,703	8,905	8,691
Net Debt	8,409	8,205	7,986	7,952	8,139	8,067	8,240	8,404	8,252	8,207	8,200
Capital Expenditures (CapEx)	32	53	41	32	46	79	55	71	46	59	53
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1,229	975	1,213	1,059	1,085	906	1,153	1,253	983	721	773
Debt-free Net Working Capital (DFNWC)	1,776	1,650	1,976	1,763	1,660	1,599	1,567	1,579	1,442	1,427	1,272
Net Working Capital (NWC)	1,756	1,630	1,966	1,754	1,651	1,590	1,559	1,571	1,434	1,419	1,264
Net Nonoperating Expense (NNE)	114	134	229	113	119	788	110	129	111	151	93
Net Nonoperating Obligations (NNO)	8,409	8,205	7,986	7,952	8,139	8,067	8,240	8,404	8,252	8,207	8,200
Total Depreciation and Amortization (D&A)	84	77	69	66	65	60	61	58	57	52	57
Debt-free, Cash-free Net Working Capital to Revenue	19.53%	15.23%	18.93%	16.69%	17.09%	14.47%	18.75%	20.31%	16.00%	11.68%	12.29%
Debt-free Net Working Capital to Revenue	28.22%	25.77%	30.83%	27.78%	26.15%	25.53%	25.48%	25.60%	23.47%	23.11%	20.22%
Net Working Capital to Revenue	27.90%	25.46%	30.68%	27.64%	26.01%	25.39%	25.35%	25.47%	23.34%	22.98%	20.09%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.34	$0.43	$1.39	$0.76	$0.78	$2.13	$0.23	$0.95	$0.70	$0.43	$0.89
Adjusted Weighted Average Basic Shares Outstanding	257.86M	257.05M	257.50M	257.29M	255.70M	255.24M	255.59M	255.34M	254.39M	254.08M	254.35M
Adjusted Diluted Earnings per Share	$0.33	$0.42	$1.38	$0.75	$0.78	$2.12	$0.23	$0.95	$0.69	$0.42	$0.89
Adjusted Weighted Average Diluted Shares Outstanding	261.00M	259.15M	259.76M	258.60M	258.36M	256.27M	256.35M	255.95M	256.17M	255.17M	255.07M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	259.96M	257.95M	257.54M	257.47M	257.17M	255.64M	255.61M	255.57M	255.06M	254.38M	254.36M
Normalized Net Operating Profit after Tax (NOPAT)	275	250	237	308	340	218	168	371	291	275	329
Normalized NOPAT Margin	18.16%	15.71%	15.00%	19.16%	20.95%	13.67%	11.07%	23.05%	18.90%	18.54%	21.42%
Pre Tax Income Margin	6.68%	8.10%	13.08%	14.62%	14.55%	6.51%	5.27%	15.80%	15.28%	7.47%	18.35%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.74	1.84	2.64	2.79	2.80	1.73	1.60	2.91	2.78	1.83	3.61
NOPAT to Interest Expense	1.48	1.59	4.67	2.35	2.44	9.33	1.26	2.79	2.18	1.93	2.97
EBIT Less CapEx to Interest Expense	1.51	1.50	2.32	2.55	2.45	1.17	1.19	2.38	2.43	1.39	3.12
NOPAT Less CapEx to Interest Expense	1.24	1.24	4.34	2.11	2.09	8.77	0.84	2.25	1.83	1.49	2.48
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	39.73%	34.38%	22.75%	29.60%	27.79%	28.74%	50.26%	38.99%	39.14%	31.62%	28.49%
Augmented Payout Ratio	39.73%	34.38%	22.75%	29.60%	27.79%	28.74%	50.26%	38.99%	39.14%	31.62%	28.49%

Frequently Asked Questions About Organon & Co.'s Financials

When does Organon & Co.'s fiscal year end?

According to the most recent income statement we have on file, Organon & Co.'s financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Organon & Co.'s net income changed over the last 5 years?

Organon & Co.'s net income appears to be on a downward trend, with a most recent value of $864 million in 2024, falling from $3.22 billion in 2019. The previous period was $1.02 billion in 2023. See Organon & Co.'s forecast for analyst expectations on what’s next for the company.

What is Organon & Co.'s operating income?

Organon & Co.'s total operating income in 2024 was $1.37 billion, based on the following breakdown:

Total Gross Profit: $3.72 billion
Total Operating Expenses: $2.34 billion

How has Organon & Co. revenue changed over the last 5 years?

Over the last 5 years, Organon & Co.'s total revenue changed from $7.78 billion in 2019 to $6.40 billion in 2024, a change of -17.7%.

How much debt does Organon & Co. have?

Organon & Co.'s total liabilities were at $12.63 billion at the end of 2024, a 4.1% increase from 2023, and a 173.2% increase since 2020.

How much cash does Organon & Co. have?

In the past 4 years, Organon & Co.'s cash and equivalents has ranged from $12 million in 2020 to $737 million in 2021, and is currently $675 million as of their latest financial filing in 2024.

How has Organon & Co.'s book value per share changed over the last 5 years?

Over the last 5 years, Organon & Co.'s book value per share changed from 0.00 in 2019 to 1.83 in 2024, a change of 183.3%.

Related Companies

This page (NYSE:OGN) was last updated on 5/27/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Organon & Co. (OGN) Financials

Frequently Asked Questions About Organon & Co.'s Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Organon & Co. (OGN) Financials

Annual Income Statements for Organon & Co.

Quarterly Income Statements for Organon & Co.

Annual Cash Flow Statements for Organon & Co.

Quarterly Cash Flow Statements for Organon & Co.

Annual Balance Sheets for Organon & Co.

Quarterly Balance Sheets for Organon & Co.

Annual Metrics And Ratios for Organon & Co.

Quarterly Metrics And Ratios for Organon & Co.

Frequently Asked Questions About Organon & Co.'s Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools